The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
IL-11 is a crucial determinant of cardiovascular fibrosis
Open accessAbstract
Fibrosis is a common pathology in cardiovascular disease. In the heart, fibrosis causes mechanical and electrical dysfunction and in the kidney, it predicts the onset of renal failure. Transforming growth factor β1 (TGFβ1) is the principal pro-fibrotic factor, but its inhibition is associated with side effects due to its pleiotropic roles. We hypothesized that downstream effectors of TGFβ1 in fibroblasts could be attractive therapeutic targets and lack upstream toxicity. Here we show, using integrated imaging-genomics analyses of primary human fibroblasts, that upregulation of interleukin-11 (IL-11) is the dominant transcriptional response to TGFβ1 exposure and required for its pro-fibrotic effect. IL-11 and its receptor (IL11RA) are expressed specifically in fibroblasts, in which they drive non-canonical, ERK-dependent autocrine signalling that is required for fibrogenic protein synthesis. In mice, fibroblast-specific Il11 transgene expression or Il-11 injection causes heart and kidney fibrosis and organ failure, whereas genetic deletion of Il11ra1 protects against disease. Therefore, inhibition of IL-11 prevents fibroblast activation across organs and species in response to a range of important pro-fibrotic stimuli. These results reveal a central role of IL-11 in fibrosis and we propose that inhibition of IL-11 is a potential therapeutic strategy to treat fibrotic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microbiota driven intestinal fibrosis may be mediated by induction of the IL-33 receptor ST2 on epithelial cells157 or the pro-fibrotic action of tumor necrosis factor-like cytokine 1A (TL1A)158”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,682
Spatial reconstruction of single-cell gene expression data
Satija, R., Farrell, J. A., Gennert, D., Schier, A. F., & Regev, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3192 · Cited by 7,055
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Cited by
Sorted by citations
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,709
CAR T cells produced in vivo to treat cardiac injury
Rurik, J. G., Tombácz, I., Yadegari, A., Méndez Fernández, P. O., Shewale, S. V., Li, L., Kimura, T., Soliman, O. Y., Papp, T. E., Tam, Y. K., et al. (2022) · Science · doi:10.1126/science.abm0594 · Cited by 1,400
Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis
Smillie, C. S., Biton, M., Ordovás-Montañés, J., Sullivan, K. M., Burgin, G., Graham, D. B., Herbst, R. H., Rogel, N., Slyper, M., Waldman, J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.029 · Cited by 1,417
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,354
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,135
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
CAR T Cells Produced in vivo to Treat Cardiac Injury
Rurik, J. G., Tombácz, I., Yadegari, A., Fernández, P. O. M., Shewale, S. V., Li, L., Kimura, T., Soliman, O. Y., Papp, T. E., Tam, Y. K., et al. (2023) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/mono/978-81-19039-63-0/ch19 · Cited by 929
Martin, J. P. D., Chang, C., Boschetti, G., Ungaro, R. C., Giri, M., Grout, J. A., Gettler, K., Chuang, L.-S. F., Nayar, S., Greenstein, A. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.008 · Cited by 890
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 888
Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784
Pathway paradigms revealed from the genetics of inflammatory bowel disease
Graham, D. B., & Xavier, R. J. (2020) · Nature · doi:10.1038/s41586-020-2025-2 · Cited by 801
Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
Friedrich, M., Pohin, M., & Powrie, F. M. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.017 · Cited by 776
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 715
The Translational Landscape of the Human Heart
van Heesch, S., Witte, F., Schneider-Lunitz, V., Schulz, J. F., Adami, E., Faber, A. B., Kirchner, M., Maatz, H., Blachut, S., Sandmann, C.-L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.010 · Cited by 637
Self-citationFarbehi, N., Patrick, R., Dorison, A., Xaymardan, M., Janbandhu, V. C., Wystub-Lis, K., Ho, J. W. K., Nordon, R. E., & Harvey, R. P. (2019) · eLife · doi:10.7554/elife.43882 · Cited by 570
Pleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
Su, J., Morgani, S. M., David, C. J., Wang, Q., Er, E. E., Huang, Y.-H., Basnet, H., Zou, Y., Shu, W., Soni, R. K., et al. (2020) · Nature · doi:10.1038/s41586-019-1897-5 · Cited by 503
The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease
Zhang, H., & Dhalla, N. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021082 · Cited by 426
Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis
Chou, C.-H., Jain, V., Gibson, J., Attarian, D. E., Haraden, C. A., Yohn, C. B., Laberge, R.-M., Gregory, S., & Kraus, V. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-67730-y · Cited by 398
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
López, B., Ravassa, S., Moreno, M. U., José, G. S., Beaumont, J., González, A., & Díez, J. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00504-1 · Cited by 383
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 352
Current treatment paradigms and emerging therapies for NAFLD/NASH
Raza, S. (2020) · Frontiers in bioscience · doi:10.2741/4892 · Cited by 329
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Ng, B., Dong, J., D’Agostino, G., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Ko, N. S. J., Tan, J., Chothani, S. P., Huang, B., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1237 · Cited by 314
Self-citationPathological mechanisms and therapeutic outlooks for arthrofibrosis
Usher, K. M., Zhu, S., Mavropalias, G., Carrino, J. A., Zhao, J., & Xu, J. (2019) · Bone Research · doi:10.1038/s41413-019-0047-x · Cited by 291
Widjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 279
Self-citationTallquist, M. D. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034527 · Cited by 276
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Rurik, J. G., Aghajanian, H. K., & Epstein, J. A. (2021) · Circulation Research · doi:10.1161/circresaha.121.318005 · Cited by 275
Early Regenerative Capacity in the Porcine Heart
Ye, L., D’Agostino, G. A., Loo, S. J., Wang, C. X., Su, L. P., Tan, S. H., Tee, G., Pua, C. J., Pena, E. M., Cheng, R. B., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.031542 · Cited by 258
Self-citationMyofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis
Tai, Y., Woods, E. L., Dally, J., Kong, D., Steadman, R., Moseley, R., & Midgley, A. C. (2021) · Biomolecules · doi:10.3390/biom11081095 · Cited by 257
Fibroblast pathology in inflammatory diseases
Wei, K., Nguyen, H. N., & Brenner, M. B. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149538 · Cited by 249
Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells
Strikoudis, A., Cieślak, A., Loffredo, L., Chen, Y.-W., Patel, N., Saqi, A., Lederer, D. J., & Snoeck, H.-W. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.077 · Cited by 242
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies
Reichart, D., Lindberg, E. L., Maatz, H., Miranda, A. M. A., Viveiros, A., Shvetsov, N., Gärtner, A., Nadelmann, E. R., Lee, M., Kanemaru, K., et al. (2022) · Science · doi:10.1126/science.abo1984 · Cited by 240
Self-citationInhibition of IL-11 signalling extends mammalian healthspan and lifespan
Widjaja, A. A., Lim, W.-W., Viswanathan, S., Chothani, S., Corden, B., Dasan, C. M., Goh, J. W. T., Lim, R., Singh, B. K., Tan, J., et al. (2024) · Nature · doi:10.1038/s41586-024-07701-9 · Cited by 238
Self-citationDilated cardiomyopathy: from epidemiologic to genetic phenotypes
Reichart, D., Magnussen, C., Zeller, T., & Blankenberg, S. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12944 · Cited by 252
Zacchigna, S., Paldino, A., Falcão‐Pires, I., Daskalopoulos, E. P., Ferro, M. D., Vodret, S., Lesizza, P., Cannata, A. N., Miranda‐Silva, D., Lourenço, A. P., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa110 · Cited by 247
Role of interleukins in the pathogenesis of pulmonary fibrosis
She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00437-9 · Cited by 231
Cardiomyocyte Senescence and Cellular Communications Within Myocardial Microenvironments
Tang, X., Li, P., & Chen, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00280 · Cited by 223
Tuleta, I., & Frangogiannis, N. G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166044 · Cited by 229
The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
Maruyama, K., & Imanaka‐Yoshida, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052617 · Cited by 230
Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities
Andreadou, I., Cabrera-Fuentes, H. A., Devaux, Y., Frangogiannis, N. G., Frantz, S., Guzik, T. J., Liehn, E. A., Gomes, C. P. C., Schulz, R., & Hausenloy, D. J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz050 · Cited by 214
Fibrosis in IBD: from pathogenesis to therapeutic targets
Rieder, F., Mukherjee, P. K., Massey, W. J., Wang, Y., & Fiocchi, C. (2024) · Gut · doi:10.1136/gutjnl-2023-329963 · Cited by 218
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Sweeney, M., Corden, B., & Cook, S. A. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910865 · Cited by 202
Self-citationCytokines in inflammatory bowel diseases – Update 2020
Leppkes, M., & Neurath, M. F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104835 · Cited by 194
Bai, X., Zhao, G., Chen, Q., Li, Z., Gao, M., Ho, W., Xu, X., & Zhang, X. (2022) · Science Advances · doi:10.1126/sciadv.abn7162 · Cited by 195
Natural Products as a Source for Antifibrosis Therapy
Chen, D., Feng, Y., Cao, G., & Zhao, Y. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.09.002 · Cited by 191
Zhang, H., Tian, L., Shen, M., Tu, C., Wu, H., Gu, M., Paik, D. T., & Wu, J. C. (2019) · Circulation Research · doi:10.1161/circresaha.119.315491 · Cited by 187
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Nagaraju, C. K., Robinson, E. L., Abdesselem, M., Trenson, S., Dries, E., Gilbert, G., Janssens, S. P., Cleemput, J. V., Rega, F., Meyns, B. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.049 · Cited by 187
TGF-beta signal transduction: biology, function and therapy for diseases
Tie, Y., Tang, F., Peng, D., Zhang, Y., & Shi, H. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00109-9 · Cited by 186
Cook, S. A., & Schäfer, S. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-041818-011649 · Cited by 178
Self-citationClearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery
Dookun, E., Walaszczyk, A., Redgrave, R., Palmowski, P., Tual‐Chalot, S., Suwana, A., Chapman, J., Jirkovsky, E., Donastorg Sosa, L., Gill, E., et al. (2020) · Aging Cell · doi:10.1111/acel.13249 · Cited by 173
Cardiac Fibrosis and Fibroblasts
Kurose, H. (2021) · Cells · doi:10.3390/cells10071716 · Cited by 178
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function
Mia, M. M., Cibi, D. M., Ghani, S. A. B. A., Singh, A., Tee, N., Viswanathan, S., Bogireddi, H., Cook, S. A., Mao, J., & Singh, M. K. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab205 · Cited by 157
Self-citationChen, H., Chen, H., Liang, J., Gu, X., Zhou, J., Xie, C., Lv, X., Wang, R., Li, Q., Mao, Z., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0371-7 · Cited by 149
Self-citationBhattacharya, M., & Ramachandran, P. (2023) · Nature Immunology · doi:10.1038/s41590-023-01551-9 · Cited by 148
Zhuang, T., Chen, M., Wu, R.-X., Wang, J., Hu, X.-D., Meng, T., Wu, A.-H., Li, Y., Yang, Y., Lei, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46357-x · Cited by 144
A myeloid–stromal niche and gp130 rescue in NOD2-driven Crohn’s disease
Nayar, S., Morrison, J. K., Giri, M., Gettler, K., Chuang, L.-S. F., Walker, L. A., Ko, H. M., Kenigsberg, E., Kugathasan, S., Mérad, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03484-5 · Cited by 141
Jia, D., Jiang, H., Weng, X., Wu, J., Bai, P., Yang, W., Wang, Z., Hu, K., Sun, A., & Ge, J. (2019) · Circulation Research · doi:10.1161/circresaha.118.314569 · Cited by 138
Nishina, T., Deguchi, Y., Ohshima, D., Takeda, W., Ohtsuka, M., Shichino, S., Ueha, S., Yamazaki, S., Kawauchi, M., Nakamura, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22450-3 · Cited by 135
Ravassa, S., López, B., Treibel, T. A., José, G. S., Losada-Fuentenebro, B., Tapia, L., Bayés‐Genís, A., Díez, J., & González, A. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101194 · Cited by 139
The Role of Interleukin-6 Family Members in Cardiovascular Diseases
Feng, Y., Ye, D., Wang, Z., Pan, H., Lu, X., Wang, M., Xu, Y. Q., Yu, J., Zhang, J., Zhao, M., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.818890 · Cited by 139
Self-citationMolecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge
Gutiérrez‐Cuevas, J., Sandoval-Rodriguez, A. S., Meza-Ríos, A., Monroy-Ramírez, H. C., Galicia‐Moreno, M., Garcia-Bañuelos, J. J., Santos, A., & Armendáriz‐Borunda, J. (2021) · Cells · doi:10.3390/cells10030629 · Cited by 133
Dong, J., Viswanathan, S., Adami, E., Singh, B. K., Chothani, S. P., Ng, B., Lim, W., Zhou, J., Tripathi, M., Ko, N. S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20303-z · Cited by 125
Self-citationPD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis
Geng, Y., Liu, X., Liang, J., Habiel, D. M., Kulur, V., Coelho, A. L., Deng, N., Xie, T., Wang, Y., Liu, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125326 · Cited by 127
Jiang, Y., Xiang, C., Zhong, F., Zhang, Y., Wang, L., Zhao, Y., Wang, J., Ding, C., Li, J., He, F., et al. (2020) · Theranostics · doi:10.7150/thno.46360 · Cited by 124
Cadinu, P., Sivanathan, K. N., Misra, A., Xu, R. J., Mangani, D., Yang, E., Rone, J. M., Tooley, K., Kye, Y.-C., Bod, L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.013 · Cited by 130
Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines
West, N. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01093 · Cited by 125
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Wang, J., Lin, S., Brown, J. M., Wagoner, D. R. V., Fiocchi, C., & Rieder, F. (2021) · Immunological Reviews · doi:10.1111/imr.12974 · Cited by 123
Single-cell transcriptomics for the assessment of cardiac disease
Miranda, A. M. A., Janbandhu, V., Maatz, H., Kanemaru, K., Cranley, J., Teichmann, S. A., Hübner, N., Schneider, M. D., Harvey, R. P., & Noseda, M. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00805-7 · Cited by 117
Self-citationWidespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins
Chothani, S. P., Schäfer, S., Adami, E., Viswanathan, S., Widjaja, A. A., Langley, S. R., Tan, J., Wang, M., Quaife, N. M., Pua, C. J., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.039596 · Cited by 122
Self-citationFibrosis: cross-organ biology and pathways to development of innovative drugs
Rieder, F., Nagy, L. E., Maher, T. M., Distler, J. H. W., Kramann, R., Hinz, B., & Prunotto, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01158-9 · Cited by 134
Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out
Zent, J. M., & Guo, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493217 · Cited by 117
Crosstalk between TGF-β and WNT signalling pathways during cardiac fibrogenesis
Działo, E., Tkacz, K., & Błyszczuk, P. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2635 · Cited by 115
Jasso, G. J., Jaiswal, A., Varma, M., Laszewski, T., Grauel, A. L., Omar, A. S., Silva, N., Dranoff, G., Porter, J. A., Mansfield, K. G., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001532 · Cited by 114
Metcalfe, R. D., Putoczki, T. L., & Griffin, M. D. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01424 · Cited by 116
Self-citationWu, J., Subbaiah, K. C. V., Xie, L. H., Jiang, F., Khor, E.-S., Mickelsen, D. M., Myers, J. R., Tang, W. H. W., & Yao, P. (2020) · Circulation Research · doi:10.1161/circresaha.119.315999 · Cited by 115
Linares, J., Sallent-Aragay, A., Badia-Ramentol, J., Recort-Bascuas, A., Méndez, A., Manero-Rupérez, N., Re, D. L., Rivas, E. I., Guiu, M., Zwick, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36334-1 · Cited by 109
Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia
Moreira, L. M., Takawale, A. R., Hulsurkar, M. M., Menassa, D. A., Antanaviciute, A., Lahiri, S. K., Mehta, N., Evans, N., Psarros, C., Robinson, P. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2890-8 · Cited by 110
Signaling cascades in the failing heart and emerging therapeutic strategies
He, X., Du, T., Long, T., Liao, X., Dong, Y., & Huang, Z. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00972-6 · Cited by 108
Emerging roles for IL-11 in inflammatory diseases
Fung, K. Y., Louis, C., Metcalfe, R. D., Kosasih, C. C., Wicks, I. P., Griffin, M. D. W., & Putoczki, T. L. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155750 · Cited by 108
Self-citationAntifibrotic Agents for the Management of CKD: A Review
Ruiz‐Ortega, M., Lamas, S., & Ortíz, A. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.11.010 · Cited by 107
Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target
Schimmel, K., Ichimura, K., Reddy, S., Haddad, F., & Spiekerkoetter, E. F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.886553 · Cited by 106
Ng, B., Cook, S. A., & Schäfer, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00531-5 · Cited by 98
Self-citationTargeting immunosenescence and inflammaging: advancing longevity research
Nguyen, T. Q. T., & Cho, K. A. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01527-9 · Cited by 100
Seyedsadr, M., Wang, Y., Elzoheiry, M., Gopal, S. S., Jang, S., Duran, G., Chervoneva, I., Kasimoglu, E., Wrobel, J. A., Hwang, D., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221007120 · Cited by 92
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
Zhang, H., Thai, P. N., Shivnaraine, R. V., Ren, L., Wu, X., Siepe, D. H., Liu, Y., Tu, C., Shin, H. S., Caudal, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.034 · Cited by 96
Steele, L., Olabi, B., Roberts, K., Mazin, P., Koplev, S., Tudor, C. L., Rumney, B. M., Admane, C., Jiang, T., Correa‐Gallegos, D., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02267-8 · Cited by 95
CXCL4 drives fibrosis by promoting several key cellular and molecular processes
Affandi, A. J., Carvalheiro, T., Ottria, A., de Haan, J. J., Brans, M. A. D., Brandt, M. M., Tieland, R. G., Lopes, A. P., Malvar‐Fernández, B., Bekker, C. P. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110189 · Cited by 86
Cardiovascular Disease: An Introduction
Thiriet, M. (2018) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-3-319-89315-0_1 · Cited by 91
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Di, X., Li, Y., Wei, J., Li, T., & Liao, B. (2024) · Advanced Science · doi:10.1002/advs.202410416 · Cited by 92
IL‐11 in cardiac and renal fibrosis: Late to the party but a central player
Corden, B., Adami, E., Sweeney, M. D., Schäfer, S., & Cook, S. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15013 · Cited by 83
Self-citationWidjaja, A. A., Dong, J., Adami, E., Viswanathan, S., Ng, B., Pakkiri, L. S., Chothani, S. P., Singh, B. K., Lim, W., Zhou, J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba8146 · Cited by 82
Self-citationTowards precision medicine in heart failure
Weldy, C. S., & Ashley, E. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00566-9 · Cited by 81
Allanki, S., Strilić, B., Scheinberger, L., Onderwater, Y. L., Marks, A., Günther, S., Preussner, J., Kikhi, K., Looso, M., Stainier, D. Y. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg6497 · Cited by 84
Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart
Umbarkar, P., Tousif, S., Singh, A. P., Anderson, J. C., Zhang, Q., Tallquist, M. D., Woodgett, J. R., & Lal, H. (2022) · Circulation Research · doi:10.1161/circresaha.122.321431 · Cited by 83
TGF-β and RAS jointly unmask primed enhancers to drive metastasis
Lee, J. H., Rivera, F. J. S., He, L. Y., Basnet, H., Chen, F., Spina, E., Li, L., Torner, C., Chan, J. E., Yarlagadda, D. V. K., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.014 · Cited by 82
Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
Mocan, M., Hognogi, L. D. M., Anton, F. P., Chiorescu, R. M., Goidescu, C. M., Stoia, M. A., & Fărcaș, A. D. (2019) · Disease Markers · doi:10.1155/2019/7583690 · Cited by 79
Widjaja, A. A., Viswanathan, S., Shekeran, S. G., Adami, E., Lim, W., Chothani, S. P., Tan, J., Goh, J. W. T., Chen, H., Lim, S. Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35306-1 · Cited by 79
Self-citation
Metadata
- Authors
- Schafer, S., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Moreno-Moral, A., DeLaughter, D. M., Ng, B., Patone, G., Chow, K., Khin, E., Tan, J., Chothani, S. P., Ye, L., Rackham, O. J. L., Ko, N. S. J., Sahib, N. E., Pua, C. J., Zhen, N. T. G., Xie, C., Wang, M., Maatz, H., Lim, S., Saar, K., Blachut, S., Petretto, E., Schmidt, S., Putoczki, T., Guimarães-Camboa, N., Wakimoto, H., van Heesch, S., Sigmundsson, K., Lim, S. L., Soon, J. L., Chao, V. T. T., Chua, Y. L., Tan, T. E., Evans, S. M., Loh, Y. J., Jamal, M. H., Ong, K. K., Chua, K. C., Ong, B.-H., Chakaramakkil, M. J., Seidman, J. G., Seidman, C. E., Hubner, N., Sin, K. Y. K., & Cook, S. A.
- Affiliations
- National University of Singapore (SG)
- National Heart Centre Singapore (SG)
- Harvard University (US)
- Max Delbrück Center (DE)
- The University of Melbourne (AU)
- KK Women's and Children's Hospital (SG)
- Brigham and Women's Hospital (US)
- Corresponding author
- Cook, Stuart A.
- ORCID
- Viswanathan, Sivakumar
- Widjaja, Anissa A.
- Lim, Wei-Wen
- DeLaughter, Daniel M.
- Ng, Benjamin
- Patone, Giannino
- Chow, Kingsley
- Chothani, Sonia P.
- Ye, Lei
- Rackham, Owen J. L.
- Pua, Chee Jian
- Xie, Chen
- Wang, Mao
- Maatz, Henrike
- Saar, Kathrin
- Blachut, Susanne
- Petretto, Enrico
- Schmidt, Sabine
- Putoczki, Tracy
- Wakimoto, Hiroko
- Chao, Victor T. T.
- Chua, Yeow L.
- Loh, Yee J.
- Jamal, Muhammad H.
- Ong, Boon-Hean
- Chakaramakkil, Mathew J.
- Seidman, Jonathan G.
- Seidman, Christine E.
- Sin, Kenny Y. K.
- Cook, Stuart A.
- Venue
- Nature
- Published
- 2017-11-13
- Volume
- 552
- Issue
- 7683
- Pages
- 110-115
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5807082
- OpenAlex
- W2770331207
- Cited by
- 639
- References
- 42
- Citations by year
- 2026: 75 · 2025: 74 · 2024: 79 · 2023: 81 · 2022: 87 · 2021: 81 · 2020: 80 · 2019: 50 · 2018: 28 · 2017: 3
- FWCI
- 33.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (acceptedVersion)
- National University of Singapore (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institutes of Health (DP1OD006428)
- National Heart, Lung, and Blood Institute (R01HL070867, DP1HL117649, R01HL080494)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- interleukin-11, IL-11 receptor, myocardial fibrosis, renal fibrosis, TGF-β1, fibroblast activation, ERK signaling, autocrine signaling, fibrotic diseases, therapeutic target, organ failure, renal failure, heart failure
- MeSH terms
- Animals, Cardiovascular System, Cells, Cultured, Female, Fibroblasts, Fibrosis, Heart, Humans, Kidney, Male, Middle Aged, Myocardium, Protein Biosynthesis, Interleukin-11, Mice, Knockout, Transgenes, Autocrine Communication, Mice, Interleukin-11 Receptor alpha Subunit, Transforming Growth Factor beta1, Organ Dysfunction Scores
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
